Clinical trial

Vortioxetine in Patients With Depression Coexisting With General Anxiety Disorder (GAD)

NCT04220996

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-12-27

PhasePHASE4

Study timeline

Study start (actual)2019-12-27Date precision: day

Registry last updated2021-04-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

MDDunresolved

Anxiety Disordersunresolved

Interventions

VortioxetineDRUG · verified · RxNorm: vortioxetine

Sponsors & collaborators

H. Lundbeck A/Slead sponsor

Mapped research locations

BarcelonaSpain2 SeoulSouth Korea1 PoznanPoland1 BialystokPoland1 LublinPoland1 BydgoszczPoland1 KatowicePoland1 RomeItaly1 TallinnEstonia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04220996 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.